Crohn's disease
Not recruitingStudy on Guselkumab for Healing in Crohn's Disease Patients
- Disease:Crohn's disease
- Substances:Guselkumab
Italy- Participants:18–64 years · 65+ years
- Substances:Guselkumab
- Sponsor:Janssen Cilag International
Rare diseases
Investigational molecules
Locations
Back to Italy689 clinical trials in Rozzano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Critical investigations focusing on various cancer types including metastatic colorectal cancer, acute myeloid leukemia, and advanced breast cancer. Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Multiple trials exploring innovative treatment approaches for both solid tumors and hematological malignancies.
Research initiatives examining treatments for idiopathic pulmonary fibrosis and chronic respiratory conditions. Studies focus on improving lung function and patient quality of life.
Investigations aim to advance therapeutic options for patients with chronic respiratory conditions.
Comprehensive research into conditions like psoriatic arthritis and systemic sclerosis. Studies evaluate new biological treatments and therapeutic approaches.
Trials focus on developing targeted therapies for various inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.